
Gynecological cancers refer to cancers that begin in a woman’s reproductive organs. These include the uterus, cervix, ovaries, fallopian tubes, vulva, and vagina. Early detection and advanced treatment can greatly improve outcomes and preserve quality of life.
At Max Hospital, Dwarka, under the care of Dr. Peush Bajpai, Director & Unit Head, Medical Oncology, women receive comprehensive, personalised care for all types of gynaecological cancers. Combining cutting-edge therapies like targeted therapy, immunotherapy, chemotherapy, and precision oncology, Dr. Bajpai ensures every patient receives world-class treatment tailored to her unique needs.
Gynecological cancers develop in the female reproductive system and differ in symptoms, progression, and treatment approaches. The main types include:
Gynecological cancers may show subtle symptoms initially, which is why regular check-ups are essential. Common signs include:
If you experience persistent or unusual symptoms, early evaluation can be life-saving.
At Max Hospital, Dwarka, Dr. Peush Bajpai and his team use advanced diagnostics to identify the type, stage, and genetic profile of the cancer. Diagnostic tools include:
Dr. Peush Bajpai offers personalised, multidisciplinary treatment plans that combine the most advanced and effective therapies available today.
Often the first step for localized cancers, surgery removes the tumour and may include nearby tissues or lymph nodes. Minimally invasive and fertility-sparing options are considered whenever possible.
Uses anti-cancer drugs to destroy cancer cells or prevent their growth. It may be administered before or after surgery or used for advanced-stage cancers.
Employs high-energy rays to target cancer cells, often used for cervical and uterine cancers in combination with chemotherapy.
Focuses on specific genetic mutations or proteins that allow cancer cells to thrive. Examples include therapies targeting HER2, VEGF, or BRCA mutations.
Stimulates the immune system to recognize and attack cancer cells. Effective in certain advanced or recurrent gynaecological cancers, particularly those with MSI-high or PD-L1 positive profiles.
Used for hormone-sensitive cancers, such as certain types of uterine and ovarian cancers, to slow growth or prevent recurrence.
Dr. Bajpai uses molecular profiling to design a treatment plan unique to each patient, maximising efficacy and minimising side effects.
These modern treatments are suitable for:
Every case is individually assessed by Dr. Peush Bajpai to ensure the safest and most effective treatment approach.
Q1. Are gynaecological cancers hereditary?
Some, such as ovarian and uterine cancers, can be linked to inherited mutations like BRCA1, BRCA2, or Lynch Syndrome. Genetic counselling and testing are recommended for high-risk women.
Q2. Can fertility be preserved during treatment?
Yes. Fertility-preserving techniques and minimally invasive surgeries can be considered in select cases.
Q3. Is immunotherapy effective for gynaecological cancers?
Yes. Immunotherapy has shown strong results in certain advanced or recurrent cases, especially those with specific biomarkers.
Q4. What is the prognosis for gynaecological cancers?
When detected early and treated appropriately, most gynaecological cancers have excellent survival rates. Advanced treatments further improve long-term outcomes.
If you or your loved one has been diagnosed with a gynaecological cancer, expert care can make all the difference.
Consult Dr. Peush Bajpai, Director & Unit Head, Medical Oncology at Max Hospital, Dwarka, for a personalised treatment plan that combines advanced medical science with compassionate care.
Empowering women with precision oncology, where care meets confidence.
Expert oncology care focused on hope, healing, and better outcomes.
Visit us on Mon–Sat, 9 AM to 5 PM.
© 2025 | Dr. Peush Bajpai | All rights reserved | Digital Marketing by Remedo